Recently, a study showed that inhibition of tumor glycolysis contributes to the therapeutic effect of CTLA-4 blockade, and the combination of CTLA-4 blockade and tumor glycolysis inhibitors may be considered (108). The gene discussed is CTLA4; the disease is neoplasm.